Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study

Serum myostatin and indoxyl sulfate (IS) levels increase with kidney function decline and may function as uremic toxins in chronic kidney disease (CKD)-related sarcopenia. Herein, we analyzed the association between serum myostatin and IS levels and sarcopenia in patients with CKD, by performing a p...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Su Mi Lee, Mi Yeun Han, Su Hyun Kim, Ran Hui Cha, Seock Hui Kang, Jun Chul Kim, Won Suk An
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-09-01
סדרה:	Toxins
נושאים:	chronic kidney disease indoxyl sulfate myostatin sarcopenia
גישה מקוונת:	https://www.mdpi.com/2072-6651/14/10/660
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!